Merck KGaA
MKGAF
$145.36
-$2.55-1.72%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 2.67% | 2.82% | -0.18% | -2.08% | -2.73% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.67% | 2.82% | -0.18% | -2.08% | -2.73% |
| Cost of Revenue | -1.20% | -0.86% | -2.04% | 8.31% | 6.67% |
| Gross Profit | 5.68% | 5.47% | 1.07% | -8.25% | -8.97% |
| SG&A Expenses | 10.61% | 0.58% | -1.25% | -2.08% | -2.47% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -252.18% | 280.46% | 182.13% | -64.27% | 210.56% |
| Total Operating Expenses | -8.89% | 0.52% | 4.06% | -0.41% | 11.42% |
| Operating Income | 75.81% | 12.61% | -19.16% | -8.94% | -46.07% |
| Income Before Tax | 25.12% | 12.31% | -13.27% | -10.16% | -19.60% |
| Income Tax Expenses | 161.55% | 18.44% | -5.32% | -4.95% | -68.98% |
| Earnings from Continuing Operations | 12.82% | 10.68% | -15.38% | -11.55% | -6.13% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -48.52% | -51.51% | 165.92% | -26.54% | 57.85% |
| Net Income | 12.70% | 10.57% | -14.74% | -11.74% | -5.73% |
| EBIT | 75.81% | 12.61% | -19.16% | -8.94% | -46.07% |
| EBITDA | 50.46% | 10.05% | -13.10% | -5.97% | -29.65% |
| EPS Basic | 12.69% | 10.51% | -14.55% | -11.50% | -5.73% |
| Normalized Basic EPS | 57.34% | 12.11% | -12.25% | -10.15% | -30.90% |
| EPS Diluted | 13.14% | 10.51% | -14.55% | -11.50% | -6.10% |
| Normalized Diluted EPS | 57.34% | 12.11% | -12.25% | -10.15% | -30.90% |
| Average Basic Shares Outstanding | 0.00% | 0.06% | -0.23% | -0.28% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.06% | -0.23% | -0.28% | 0.00% |
| Dividend Per Share | -0.99% | -- | -- | -- | 5.37% |
| Payout Ratio | -- | -- | 0.07% | -0.34% | -- |
